Abstract:Objectives: Recent studies have revealed an association between coronary risk factors and both the number and function of bone marrow-derived endothelial progenitor cell (EPC). We investigated the effect of angiotensin II (Ang II) on EPC senescence, leading to the impairment of proliferative activity. Methods and results: EPCs were isolated from peripheral blood and characterized. Both reverse transcription (RT)-polymerase chain reaction (PCR) and Western blotting were used to assess gp91phox expression. Immunofluorescence of nitrotyrosine provided evidence of peroxynitrite formation. Our data indicate that Ang II increased the expression of gp91phox mRNA in a dose-dependent manner, which was attenuated by Ang II type 1 (AT1) receptor antagonist valsartan. Similarly, Western blotting revealed that Ang II stimulated an increase in gp91phox, whereas pre-treatment with Valsartan reduced the Ang II-induced expression of gp91phox protein. Valsartan as well as superoxide dismutase (SOD) also inhibited Ang II-induced peroxynitrite formation. The exposure of cultured EPC to Ang II (100 nmol/l) significantly accelerated the rate of senescence compared to a control during 14 days in culture as determined by acidic beta-galactosidase staining. Ang II-induced EPC senescence was significantly inhibited by pre-treatment of either valsartan or SOD (P < 0.01). Because cellular senescence is critically influenced by telomerase, which elongates telomeres, we measured telomerase activity by using PCR-enzyme-linked immunosorbent-based assay. Ang II significantly diminished telomerase activity, although the effect was significantly reduced by pre-treatment with either valsartan or SOD (P < 0.01). We examined whether Ang II-induced EPC senescence translates into an impairment of EPC proliferation. MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenol)-2-(4-sulfophenyl)-2H-tetrazolium] assay disclosed an inhibitory effect of Ang II on EPC proliferation. Conclusions: Ang II increases gp91phox expression in EPC, which may contribute to oxidative stress, as evidenced by peroxynitrite formation. Ang II accelerates the onset of EPC senescence via increased oxidative stress, which may be related to telomerase inactivation. In addition, Ang II-induced EPC senescence leads to the impairment of proliferative activity.

Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells

Reduced Number and Activity of Circulating Endothelial Progenitor Cells from Patients with Hyperhomocysteinemia.

Stromal Cell‐derived Factor 1α Reduces Senescence of Endothelial Progenitor Subpopulation in Lectin‐binding and DiLDL‐uptaking Cell Through Telomerase Activation and Telomere Elongation

Homocysteine Accelerates Senescence of Endothelial Cells Via DNA Hypomethylation of Human Telomerase Reverse Transcriptase.

High Glucose And Free Fatty Acids Induce Endothelial Progenitor Cell Senescence Via Pgc-1 Alpha/Sirt1 Signaling Pathway

Study on Effects of Cigarette Smoke Extract on Senescence of Endothelial Progenitor Cells from Peripheral Blood and Its Mechanisms

Puerarin Reduces Endothelial Progenitor Cells Senescence Through Augmentation of Telomerase Activity

Ginkgo Biloba Extract Reduces Endothelial Progenitor-Cell Senescence Through Augmentation of Telomerase Activity

Corrigendum to “Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood” [J. Mol. Cell. Cardiol. 36 (2004) 233–239]

Atorvastatin Inhibits Homocysteine-Induced Dysfunction and Apoptosis in Endothelial Progenitor Cells.

Inhibition of S-adenosylhomocysteine Hydrolase Induces Endothelial Senescence Via Htert Downregulation.

Homocysteine Inhibits Endothelial Progenitor Cells Proliferation Via DNMT1-mediated Hypomethylation of Cyclin A.

Homocysteine Impaired Endothelial Function Through Compromised Vascular Endothelial Growth Factor/Akt/Endothelial Nitric Oxide Synthase Signalling

Homocysteine impaired endothelial function via compromised VEGF/Akt/eNOS signaling (Revised 1)

Resveratrol Reduces Endothelial Progenitor Cells Senescence Through Augmentation of Telomerase Activity by Akt‐dependent Mechanisms

Homocysteine Induces Apoptosis of Human Umbilical Vein Endothelial Cells via Mitochondrial Dysfunction and Endoplasmic Reticulum Stress

Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress

Phosphoenolpyruvate induces endothelial dysfunction and cell senescence through stimulation of metabolic reprogramming

Homocysteine-induced decrease in HUVEC cells’ resistance to oxidative stress is mediated by Akt-dependent changes in iron metabolism

Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells

HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes